Achleitner Lena, Winter Martina, Aguilar Patricia Pereira, Lingg Nico, Jungbauer Alois, Klausberger Miriam, Satzer Peter
acib - Austrian Centre of Industrial Biotechnology, Muthgasse 11, 1190 Vienna, Austria; Institute of Bioprocess Science and Engineering, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna (BOKU), Muthgasse 18, 1190 Vienna, Austria.
Institute of Molecular Biotechnology, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna (BOKU), Muthgasse 18, 1190 Vienna, Austria.
N Biotechnol. 2024 May 25;80:46-55. doi: 10.1016/j.nbt.2024.01.002. Epub 2024 Feb 1.
The aim of this study was the development of a scalable production process for high titer (10 pfu/mL and above) recombinant baculovirus stocks with low cell line-derived impurities for the production of virus-like particles (VLP). To achieve this, we developed a high cell density (HCD) culture for low footprint cell proliferation, compared different infection strategies at multiplicity of infection (MOI) 0.05 and 0.005, different infection strategies and validated generally applicable harvest criteria of cell viability ≤ 80%. We also investigated online measurable parameters to observe the baculovirus production. The infection strategy employing a very low virus inoculum of MOI 0.005 and a 1:2 dilution with fresh medium one day after infection proved to be the most resource efficient. There, we achieved higher cell-specific titers and lower host cell protein concentrations at harvest than other tested infection strategies with the same MOI, while saving half of the virus stock for infecting the culture compared to other tested infection strategies. HCD culture by daily medium exchange was confirmed as suitable for seed train propagation, infection, and baculovirus production, equally efficient as the conventionally propagated seed train. Online measurable parameters for cell concentration and average cell diameter were found to be effective in monitoring the production process. The study concluded that a more efficient VLP production process in large scale can be achieved using this virus stock production strategy, which could also be extended to produce other proteins or extracellular vesicles with the baculovirus expression system.
本研究的目的是开发一种可扩展的生产工艺,用于生产高滴度(10 pfu/mL及以上)、细胞系衍生杂质低的重组杆状病毒储备液,以用于生产病毒样颗粒(VLP)。为实现这一目标,我们开发了一种高细胞密度(HCD)培养方法以实现低占地面积的细胞增殖,比较了感染复数(MOI)为0.05和0.005时的不同感染策略、不同感染策略,并验证了细胞活力≤80%这一普遍适用的收获标准。我们还研究了在线可测量参数以观察杆状病毒的生产情况。结果表明,采用MOI为0.005的极低病毒接种量并在感染后一天用新鲜培养基进行1:2稀释的感染策略最为节省资源。在此策略下,与相同MOI的其他测试感染策略相比,收获时我们获得了更高的细胞特异性滴度和更低的宿主细胞蛋白浓度,同时与其他测试感染策略相比,用于感染培养物的病毒储备液节省了一半。通过每日更换培养基进行的HCD培养被证实适用于种子批传代、感染和杆状病毒生产,与传统传代的种子批效率相当。发现细胞浓度和平均细胞直径的在线可测量参数可有效监测生产过程。该研究得出结论,使用这种病毒储备液生产策略可实现大规模更高效的VLP生产工艺,该策略还可扩展用于用杆状病毒表达系统生产其他蛋白质或细胞外囊泡。